SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History

This study attempted to understand the levels of neutralizing titers and the breadth of antibody protection against wild-type and variant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Canadian blood donors during the first 3 months of 2021. During this period, it is unlikely that m...

Descripción completa

Detalles Bibliográficos
Autores principales: Drews, Steven J., Hu, Queenie, Samson, Reuben, Abe, Kento T., Rathod, Bhavisha, Colwill, Karen, Gingras, Anne-Claude, Yi, Qi-Long, O’Brien, Sheila F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849073/
https://www.ncbi.nlm.nih.gov/pubmed/35171006
http://dx.doi.org/10.1128/spectrum.02262-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849073/
https://www.ncbi.nlm.nih.gov/pubmed/35171006
http://dx.doi.org/10.1128/spectrum.02262-21

Ejemplares similares